Entera BioENTX
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 26 institutions reported holding Entera Bio Ltd. (ENTX) in their 13F filings, up 4 from Q4 2025. 8 opened new positions and 4 sold out. The largest holders were Knoll Capital Management, LLC ($6.5M), Renaissance Technologies ($526K) and Parkman Healthcare Partners LLC ($320K). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Entera Bio Ltd.
- CUSIP
- M40527109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $203K |
| Exits | 4 | $206K |
All 13F filers, Q4 2025 → Q1 2026: 841,631 shares bought and 2,312,725 shares sold, net −1,471,094 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| Knoll Capital Management, LLC | 3.43% | No change | 5,881,879 | $6.5M |
| Renaissance Technologies | 0.00% | Add +338.4% | 473,442 | $526K |
| Parkman Healthcare Partners LLC | 0.03% | Add +4.9% | 288,670 | $320K |
| Citadel Advisors | 0.00% | Add +510.4% | 245,577 | $273K |
| Seven Fleet Capital Management LP | 0.07% | Add +51.9% | 205,542 | $228K |
| Marshall Wace, LLP | 0.00% | Reduce -68.8% | 195,780 | $217K |
| Northern Trust Corp. | 0.00% | Reduce -1.2% | 146,854 | $163K |
| XTX Topco Ltd | 0.00% | New | 131,622 | $146K |
| Schonfeld Strategic Advisors LLC | 0.00% | Reduce -90.7% | 55,223 | $61K |
| Signature Estate & Investment Advisors LLC | 0.00% | No change | 47,328 | $53K |
| HighTower Advisors, LLC | 0.00% | Reduce -14.6% | 36,830 | $41K |
| Jane Street Group, LLC | 0.00% | Reduce -55.6% | 32,915 | $37K |
| Diadema Partners LP | 0.01% | New | 23,260 | $26K |
| Geode Capital Management, LLC | 0.00% | No change | 21,136 | $23K |
| Gem Investment Advisors, LLC | 0.02% | No change | 19,135 | $21K |
| HRT Financial LP | 0.00% | New | 15,492 | $17K |
| Point72 Asset Management | 0.00% | Reduce -99.0% | 12,382 | $14K |
| Bank of America Corp. | 0.00% | Reduce -20.0% | 12,000 | $13K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 10,000 | $11K |
| JPMorgan Chase & Co. | 0.00% | New | 7,150 | $7K |
| Persistent Asset Partners Ltd | 0.00% | New | 5,881 | $7K |
| UBS Group AG | 0.00% | Add +18794.1% | 3,212 | $4K |
| Morgan Stanley | 0.00% | New | 400 | $444 |
| Group One Trading LLC | 0.00% | No change | 51 | $57 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 20 | $22 |
| SBI Securities Co., Ltd. | 0.00% | New | 2 | $2 |
"% of holder's portfolio" is ENTX's weight in each manager's 13F, not the share of Entera Bio Ltd. the manager owns.